Topics
-
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
-
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
-
Nagasaki University signed an MOU with the International Vaccine Institute (IVI)
-
Nagasaki University held a launching ceremony for the DEJIMA Infectious Disease Research Alliance and the National Research Center for the Control and Prevention of Infectious Diseases.
-
Nagasaki University Selected as One of the Vaccine Development Centers in Japan, aiming to Supply Vaccines within 100 Days of a Pandemic Outbreak: World-Leading R&D Center Program for Vaccine Development funded by AMED